RT @DrBenjaminTan: Our study in @IntJStroke shows young adults face significant stroke recurrence risks: 4.5-7.3% recurrence rate within ju….

RT @DavidSeiffge: LAAO and stroke: We summarize current evidence & ongoing trials: promising option for AF patients to avoid OAC (i.e. afte….

All the initial processes have a flow on effect to subsequent steps such as organising thrombectomy. Door to complete perfusion (under GA) just over 70min, which is amazing for NZ, and NIHSS 19 to 0. Everyone involved played a vital role!.

RT @emlitofnote: @Teddyyhwu Thanks to our amazing prehospital team and ED nurses, too!.

Door to needle time 13min. Still got it….

RT @DavidSeiffge: Great to see our review on intracerebral haemorrhage now published in @NatRevNeurol ! Great collaboration with @SimonFaHo….

Christmas just arrived.

RT @BLACKCAPS: The first New Zealand team to win a Test series in India 🏏 #INDvNZ #CricketNation

RT @ShadiYaghi2: Really enjoyed the debate on IVT in DOAC patients with my friend & colleague @DavidSeiffge .More data is needed to support….

RT @MichaelOkun: Is Hoover's sign only useful in functional neurological disorders? NOPE. Wonderful experience teaching @UFNeuroRes as the….

RT @DrBenjaminTan: We report differences in #stroke outcomes in #TNK vs. #alteplase stratified by ethnicity. In Asian cohorts, TNK had high….

Hyvää Juhannusta!! To all the Finns in the world!

RT @AshuPJadhav: Tenecteplase versus alteplase in stroke thrombolysis: the last piece of the puzzle? - The Lancet Neurology .

RT @DavidSeiffge: @stephanamayer @hoomankamel We did it 3 times this week; 3hours after last intake of 5mg of Apixaban - no bleeding and di….

RT @DavidSeiffge: It was a pleasure having long-time collaborator and friend @Teddyyhwu for a few days with us in @StrokeBern @inselgruppe….

RT @StrokeBern: Many thanks to Alastair Webb for a fascinating comprehensive talk on #brainhealth and beyond at the @StrokeBern cluster mee….

RT @ESOstroke: #TRACE3 RCT: TNK (0.25mg/kg) vs BMT for stroke patients between 4.5 - 24h without access to EVT. TNK improved excellent outc….

RT @ESOstroke: The #TASTE #trial supports the use of #Tenecteplase for acute ischemic #stroke <4.5h. Though neutral in the intention-to-tre….

Astounding. I dare say better than TICI 3

RT @DavidSeiffge: Join us in Basel for this exciting ESOC. Be the first to see the main results of many important trials including @SWITCH_….